Literature DB >> 29401315

Vaccine-Associated Maintenance of Epithelial Integrity Correlated With Protection Against Virus Entry.

L Shang1, A J Smith1, L Duan1, K E Perkey1, S Wietgrefe1, M Zupancic1, P J Southern1, R P Johnson2, J V Carlis3, A T Haase1.   

Abstract

To identify the mechanisms by which human immunodeficiency virus type 1 (HIV-1) might penetrate the epithelial barrier during sexual transmission to women and the mechanisms of vaccine-associated protection against entry, we characterized early epithelial responses to vaginal inoculation of simian immunodeficiency virus strain mac251 (SIVmac251) in naive or SIVmac239Δnef-vaccinated rhesus macaques. Vaginal inoculation induced an early stress response in the cervicovaginal epithelium, which was associated with impaired epithelial integrity, damaged barrier function, and virus and bacterial translocation. In vaccinated animals, early stress responses were suppressed, and the maintenance of epithelial barrier integrity correlated with prevention of virus entry. These vaccine-protective effects were associated with a previously described mucosal system for locally producing and concentrating trimeric gp41 antibodies at the mucosal interface and with formation of SIV-specific immune complexes that block the stress responses via binding to the epithelial receptor FCGR2B and subsequent inhibitory signaling. Thus, blocking virus entry may be one protective mechanism by which locally concentrated non-neutralizing Ab might prevent HIV sexual transmission to women.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29401315      PMCID: PMC6455945          DOI: 10.1093/infdis/jiy062

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  38 in total

1.  25 years of HIV.

Authors:  Anthony S Fauci
Journal:  Nature       Date:  2008-05-15       Impact factor: 49.962

2.  Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.

Authors:  M Bomsel; M Heyman; H Hocini; S Lagaye; L Belec; C Dupont; C Desgranges
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

3.  Comparative characterization of transfection- and infection-derived simian immunodeficiency virus challenge stocks for in vivo nonhuman primate studies.

Authors:  Gregory Q Del Prete; Matthew Scarlotta; Laura Newman; Carolyn Reid; Laura M Parodi; James D Roser; Kelli Oswald; Preston A Marx; Christopher J Miller; Ronald C Desrosiers; Dan H Barouch; Ranajit Pal; Michael Piatak; Elena Chertova; Luis D Giavedoni; David H O'Connor; Jeffrey D Lifson; Brandon F Keele
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

4.  Live simian immunodeficiency virus vaccine correlate of protection: immune complex-inhibitory Fc receptor interactions that reduce target cell availability.

Authors:  Anthony J Smith; Stephen W Wietgrefe; Liang Shang; Cavan S Reilly; Peter J Southern; Katherine E Perkey; Lijie Duan; Heinz Kohler; Sybille Müller; James Robinson; John V Carlis; Qingsheng Li; R Paul Johnson; Ashley T Haase
Journal:  J Immunol       Date:  2014-08-20       Impact factor: 5.422

5.  Quantitative image analysis of HIV-1 infection in lymphoid tissue.

Authors:  A T Haase; K Henry; M Zupancic; G Sedgewick; R A Faust; H Melroe; W Cavert; K Gebhard; K Staskus; Z Q Zhang; P J Dailey; H H Balfour; A Erice; A S Perelson
Journal:  Science       Date:  1996-11-08       Impact factor: 47.728

6.  Highly attenuated vaccine strains of simian immunodeficiency virus protect against vaginal challenge: inverse relationship of degree of protection with level of attenuation.

Authors:  R P Johnson; J D Lifson; S C Czajak; K S Cole; K H Manson; R Glickman; J Yang; D C Montefiori; R Montelaro; M S Wyand; R C Desrosiers
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 7.  Living with p53, dying of p53.

Authors:  Yael Aylon; Moshe Oren
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

Review 8.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1.

Authors:  Florian Hladik; Polachai Sakchalathorn; Lamar Ballweber; Gretchen Lentz; Michael Fialkow; David Eschenbach; M Juliana McElrath
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

10.  Persistent Low-Level Replication of SIVΔnef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.

Authors:  Sama Adnan; R Keith Reeves; Jacqueline Gillis; Fay E Wong; Yi Yu; Jeremy V Camp; Qingsheng Li; Michelle Connole; Yuan Li; Michael Piatak; Jeffrey D Lifson; Wenjun Li; Brandon F Keele; Pamela A Kozlowski; Ronald C Desrosiers; Ashley T Haase; R Paul Johnson
Journal:  PLoS Pathog       Date:  2016-12-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.